Zydus receives EIR for the injectable facility located at Jarod

Zydus Lifesciences Ltd has received the Establishment Inspection Report (EIR) from the USFDA for a GMP follow-up inspection conducted at its injectable facility located at Jarod, Vadodara from August 25 to September 5, 2025 and classifying the facility as Voluntary Action Indicated (VAI). This inspection was conducted following the Warning Letter issued on August 29, 2024 by the USFDA.

Shares of Zydus Lifesciences Limited was last trading in BSE at Rs. 931.45 as compared to the previous close of Rs. 935.20. The total number of shares traded during the day was 10837 in over 1122 trades.

The stock hit an intraday high of Rs. 936.60 and intraday low of 929.50. The net turnover during the day was Rs. 10106078.00.

Source : Equity Bulls

Keywords

ZydusLifesciences INE010B01027 Pharmaceuticals EIR InjectableFacility Jarod